To view this email as a web page, click here.

Breaking Down Chronic Pain in Cancer Survivors

This new study looked at chronic pain rates among cancer survivors, including which survivors report the highest prevalence of pain.

Sorafenib Impacted Survival Rates in Acute Myeloid Leukemia

The addition of sorafenib to intensive chemotherapy had a significant impact on the survival rate of patients with FLT3-internal tandem duplication mutation-positive acute myeloid leukemia.

IN CASE YOU MISSED IT

Use of Metformin Disappoints in DLBCL, Follicular Lymphoma

Cell of origin and dual expressor/double-hit status may not confer prognosis as originally suspected.

One FDA-approved test analyzes 324 cancer-relevant genes

FoundationOne®CDx analyzes all recommended genomic biomarkers for solid tumors and provides direct paths to therapy for companion diagnostic indications. This one test can help guide therapy selection and clinical trial options for more patients.

Read more.

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.